Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
DHR
Danaher
$189.73
Chart
205.85
203.59
231.1
262.78
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
DHR
Danaher
$189.73
Chart
205.85
203.59
231.1
262.78
DHR Latest Headlines
Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight. Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 |. DelveInsightThe growing prevalence of chronic and infectious diseases is a major driver behind the rising demand for immunodiagnostics. Moreover the increasing need for point-of-care testing and the surge in product launches within the immunodiagnostics sector are key factors contributing to the market'.s growth during the forecast peri
Thu May 8, 2025
Danaher to Present at Bank of America Securities Healthcare Conference. WASHINGTON May 7 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer Rainer M. Blair will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas Nevada on Thursday May 15 2025 at 10:00 a.m. PT....
Wed May 7, 2025
Danaher declares $0.32 dividend.
Tue May 6, 2025
Danaher: A Capital Intensive Business Offering Low Risk Low Reward Opportunity.
Tue May 6, 2025
Danaher: Q1 Beat Fails To Trigger Guidance Upgrade.
Fri May 2, 2025
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight. Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine |. DelveInsightThe molecular diagnostics market is experiencing significant growth driven by advancements in technology increasing demand for personalized medicine and the rising prevalence of chronic diseases. Innovations such as next-genera
Thu May 1, 2025
Danaher Corporation (DHR): Among Billionaire Ken Fishers Healthcare Stock Picks with Massive Upside Potential.
Mon Apr 28, 2025
Market Whales and Their Recent Bets on DHR Options. Whales with a lot of money to spend have taken a noticeably bearish stance on Looking at options history for Danaher (NYSE:) we detected 16 trades.If we consider the specifics of each trade it is accurate to state that 37% of the investors opened trades with ish expectations and 56% with bearish.From the overall spotted trades 14 are puts for a total amount of $1099493 and 2 calls for a total amount of $324480.Based on the trading activity it a
Fri Apr 25, 2025
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today. Danaher (NYSE:) has outperformed the market over the past 10 years by 3.44% on an annualized basis producing an average annual return of 13.45%. Currently Danaher has a market capitalization of $140.63 billion.
Thu Apr 24, 2025
Analyst Sees Opportunity In Danaher Stock As Sentiment Improves. ) on Tuesday reported first-quarter 2025 sales of $5.74 billion down 1% year-over-year beating the.Non-GAAP core revenue was flat compared to the expectations of a decline by a low-single-digit percentage year-over-year.Danaher reported second-quarter adjusted EPS of $1.88down from $1.92 a year ago.Stifel on Tuesday wrote “.DHR’.s start to the year was solid as the company posted a beat and gave positive commentary around
Wed Apr 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Login to display Danaher (DHR) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
